THE 2026/2027 BARKLEY AGACNP
ARCHITECT'S BLUEPRINT: ELITE TEST
BANK
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
● PART II: THE ELITE TEST BANK
○ Questions 1–15: Foundational Syntax & Application
○ Questions 16–40: Professional Simulation
○ Questions 41–66: Grandmaster Synthesis
PART I: THE PRIMER
Mastering this specific niche separates compliant technicians from exceptional clinical
architects; it forges acute care practitioners whose mechanistic precision prevents systemic
crises and commands top-tier professional equity. The apprentice relies on rote memorization;
the master relies on first-principles debugging to reverse-engineer physiological collapse.
The "Panic Button" Cheat Sheet:
● Cardiovascular Risk (PREVENT 2026): Replace the obsolete PCE. The treatment
threshold for Stage 1 HTN is a 10-year total CVD risk ≥7.5%.
● Pediatric Sepsis (Phoenix Criteria): Discard SIRS. Sepsis is now strictly defined as a
Phoenix Sepsis Score ≥2 (respiratory, cardiovascular, coagulation, neurological).
● Asthma (GINA 2026): SABA-only therapy is dead. Track 1 requires ICS-formoterol as
both maintenance and reliever therapy (MART).
● Stroke (AHA 2026): Tenecteplase is equal/preferred to alteplase. EVT windows extend
up to 24 hours for select large-core infarcts.
● Hepatology (MASH/MASLD): Resmetirom is the 2026 standard for non-cirrhotic MASH
(F2-F3). Semaglutide is the GLP-1 alternative.
● Billing (G2211) & Compliance (NPG 12): Use HCPCS G2211 for longitudinal E/M
complexity. Joint Commission NPG 12 mandates strict competency-based staffing,
explicitly discarding generalized ratios.
PART II: THE ELITE TEST BANK
Foundational Syntax & Application
Q1: A 6-year-old child presents to the emergency department with a suspected systemic
infection. Under the 2026/2027 guidelines, which diagnostic parameter is the MOST
APPROPRIATE for diagnosing pediatric sepsis? A) Two or more positive Systemic
Inflammatory Response Syndrome (SIRS) criteria, including abnormal temperature or leukocyte
,count. B) A Phoenix Sepsis Score of 2 or greater, evaluating respiratory, cardiovascular,
coagulation, and neurologic dysfunction. C) A drop in mean arterial pressure (MAP) requiring
vasoactive medication administration. D) An elevated serum lactate greater than 2 mmol/L
combined with tachycardia.
● The Answer: B (A Phoenix Sepsis Score of 2 or greater, evaluating respiratory,
cardiovascular, coagulation, and neurologic dysfunction.)
● Distractor Analysis:
○ A is incorrect: SIRS is overly sensitive, lacks specificity, and was explicitly discarded
by the SCCM task force for pediatric sepsis.
○ C is incorrect: This describes pediatric septic shock, which requires the sepsis
criteria plus at least 1 cardiovascular point, not baseline sepsis.
○ D is incorrect: While lactate is a component of the cardiovascular domain, it alone
does not diagnose sepsis under the new framework.
The Mentor's Analysis: The pediatric physiological reserve masks hypoperfusion until
catastrophic collapse. The Phoenix criteria eliminated the "noise" of SIRS to focus strictly on
life-threatening organ dysfunction.
Phoenix Score Domains Clinical Markers
Respiratory PaO2/FiO2 ratio, need for mechanical
ventilation
Cardiovascular Lactate levels, need for vasoactive medications
Coagulation Platelet count, INR, D-dimer, Fibrinogen
Neurological Glasgow Coma Scale (GCS), pupillary
reactivity
Professional Intuition: Do not wait for hypotension in a child; if the Phoenix score hits 2,
initiate aggressive resuscitation immediately.
Q2: A 45-year-old male without known cardiovascular disease presents for an annual exam. His
blood pressure is 134/86 mmHg. According to the 2025/2026 AHA/ACC High Blood Pressure
Guidelines, which tool is the INITIAL requirement to determine if antihypertensive
pharmacotherapy is indicated? A) The Pooled Cohort Equations (PCE) to assess 10-year
ASCVD risk. B) An immediate 24-hour ambulatory blood pressure monitor (ABPM). C) The
PREVENT-CVD equation to estimate the 10-year risk of total cardiovascular disease. D) An
electrocardiogram to assess for left ventricular hypertrophy.
● The Answer: C (The PREVENT-CVD equation to estimate the 10-year risk of total
cardiovascular disease.)
● Distractor Analysis:
○ A is incorrect: The PCE was retired in the 2025/2026 guidelines due to improved
calibration and the inclusion of heart failure in the newer PREVENT tool.
○ B is incorrect: While ABPM is useful for confirming resistant hypertension or
white-coat hypertension, it does not replace the risk-stratification calculation for
initiating therapy.
○ D is incorrect: End-organ damage assessment is secondary; the risk calculator
dictates the primary treatment threshold.
The Mentor's Analysis: The paradigm has shifted from isolated atherosclerosis prediction to
global cardiovascular-kidney-metabolic (CKM) risk. The PREVENT equation captures heart
failure and utilizes a lowered threshold (≥7.5%). Professional Intuition: Treat the patient's
global trajectory, not just the isolated sphygmomanometer reading.
Q3: Under the 2026 Global Initiative for Asthma (GINA) guidelines, which intervention is
, STRONGLY CONTRAINDICATED for the standalone management of a 22-year-old patient with
mild asthma? A) As-needed low-dose budesonide-formoterol. B) Daily low-dose inhaled
corticosteroids with as-needed short-acting beta-agonists. C) As-needed short-acting
beta-agonists (SABA) alone without concurrent anti-inflammatory therapy. D) Daily leukotriene
receptor antagonists.
● The Answer: C (As-needed short-acting beta-agonists (SABA) alone without concurrent
anti-inflammatory therapy.)
● Distractor Analysis:
○ A is incorrect: This is Track 1 (Preferred) therapy for mild asthma.
○ B is incorrect: This is Track 2 therapy, which is acceptable if Track 1 is unavailable
or unfeasible.
○ D is incorrect: While not first-line, LTRAs are not contraindicated, unlike standalone
SABAs.
The Mentor's Analysis: SABA monotherapy masks airway remodeling while providing a false
sense of security, directly leading to preventable asthma fatalities. Professional Intuition:
Never prescribe a bronchodilator without a structural fire extinguisher (ICS).
Q4: A 68-year-old patient arrives via EMS with an acute ischemic stroke (AIS) with symptom
onset 3 hours ago. The patient has disabling deficits. According to the 2026 AHA/ASA
guidelines, what is the PREFERRED intravenous thrombolytic strategy? A) Administer alteplase
exclusively, as newer agents are strictly investigational. B) Administer either alteplase or
tenecteplase without delaying for advanced perfusion imaging. C) Delay thrombolysis until an
MRI confirms the exact penumbra volume. D) Bypass intravenous thrombolysis entirely and
proceed directly to endovascular thrombectomy (EVT).
● The Answer: B (Administer either alteplase or tenecteplase without delaying for
advanced perfusion imaging.)
● Distractor Analysis:
○ A is incorrect: Tenecteplase (0.25 mg/kg) is fully endorsed and often preferred due
to its single-bolus administration.
○ C is incorrect: Advanced imaging (CTP/MRI) is for the extended window (4.5–24
hrs), not the standard 4.5-hour window.
○ D is incorrect: If eligible for both IVT and EVT, the guidelines mandate administering
IVT rapidly prior to or concurrent with EVT.
The Mentor's Analysis: Time is brain. Within the 4.5-hour window, standard non-contrast CT to
rule out hemorrhage is the only imaging barrier to the needle. Professional Intuition: Treat the
clot at the door; mechanical extraction is a concurrent pathway, never a reason to delay
chemical lysis.
Q5: A 55-year-old female presents with elevated liver enzymes, obesity, and type 2 diabetes.
Ultrasound reveals significant hepatic steatosis. She consumes zero alcohol. Under 2026
hepatology nomenclature, what is the MOST ACCURATE diagnostic term for her condition? A)
Non-Alcoholic Fatty Liver Disease (NAFLD). B) Metabolic Dysfunction-Associated Steatotic
Liver Disease (MASLD). C) Cryptogenic Cirrhosis. D) Alcohol-Associated Liver Disease (ALD).
● The Answer: B (Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).)
● Distractor Analysis:
○ A is incorrect: NAFLD is an obsolete, stigmatizing legacy term replaced in
2023/2026 by MASLD.
○ C is incorrect: She is not cirrhotic yet, and the etiology (metabolic) is clearly
identified.
○ D is incorrect: She consumes zero alcohol; Met-ALD requires 20-50g of alcohol per
ARCHITECT'S BLUEPRINT: ELITE TEST
BANK
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
● PART II: THE ELITE TEST BANK
○ Questions 1–15: Foundational Syntax & Application
○ Questions 16–40: Professional Simulation
○ Questions 41–66: Grandmaster Synthesis
PART I: THE PRIMER
Mastering this specific niche separates compliant technicians from exceptional clinical
architects; it forges acute care practitioners whose mechanistic precision prevents systemic
crises and commands top-tier professional equity. The apprentice relies on rote memorization;
the master relies on first-principles debugging to reverse-engineer physiological collapse.
The "Panic Button" Cheat Sheet:
● Cardiovascular Risk (PREVENT 2026): Replace the obsolete PCE. The treatment
threshold for Stage 1 HTN is a 10-year total CVD risk ≥7.5%.
● Pediatric Sepsis (Phoenix Criteria): Discard SIRS. Sepsis is now strictly defined as a
Phoenix Sepsis Score ≥2 (respiratory, cardiovascular, coagulation, neurological).
● Asthma (GINA 2026): SABA-only therapy is dead. Track 1 requires ICS-formoterol as
both maintenance and reliever therapy (MART).
● Stroke (AHA 2026): Tenecteplase is equal/preferred to alteplase. EVT windows extend
up to 24 hours for select large-core infarcts.
● Hepatology (MASH/MASLD): Resmetirom is the 2026 standard for non-cirrhotic MASH
(F2-F3). Semaglutide is the GLP-1 alternative.
● Billing (G2211) & Compliance (NPG 12): Use HCPCS G2211 for longitudinal E/M
complexity. Joint Commission NPG 12 mandates strict competency-based staffing,
explicitly discarding generalized ratios.
PART II: THE ELITE TEST BANK
Foundational Syntax & Application
Q1: A 6-year-old child presents to the emergency department with a suspected systemic
infection. Under the 2026/2027 guidelines, which diagnostic parameter is the MOST
APPROPRIATE for diagnosing pediatric sepsis? A) Two or more positive Systemic
Inflammatory Response Syndrome (SIRS) criteria, including abnormal temperature or leukocyte
,count. B) A Phoenix Sepsis Score of 2 or greater, evaluating respiratory, cardiovascular,
coagulation, and neurologic dysfunction. C) A drop in mean arterial pressure (MAP) requiring
vasoactive medication administration. D) An elevated serum lactate greater than 2 mmol/L
combined with tachycardia.
● The Answer: B (A Phoenix Sepsis Score of 2 or greater, evaluating respiratory,
cardiovascular, coagulation, and neurologic dysfunction.)
● Distractor Analysis:
○ A is incorrect: SIRS is overly sensitive, lacks specificity, and was explicitly discarded
by the SCCM task force for pediatric sepsis.
○ C is incorrect: This describes pediatric septic shock, which requires the sepsis
criteria plus at least 1 cardiovascular point, not baseline sepsis.
○ D is incorrect: While lactate is a component of the cardiovascular domain, it alone
does not diagnose sepsis under the new framework.
The Mentor's Analysis: The pediatric physiological reserve masks hypoperfusion until
catastrophic collapse. The Phoenix criteria eliminated the "noise" of SIRS to focus strictly on
life-threatening organ dysfunction.
Phoenix Score Domains Clinical Markers
Respiratory PaO2/FiO2 ratio, need for mechanical
ventilation
Cardiovascular Lactate levels, need for vasoactive medications
Coagulation Platelet count, INR, D-dimer, Fibrinogen
Neurological Glasgow Coma Scale (GCS), pupillary
reactivity
Professional Intuition: Do not wait for hypotension in a child; if the Phoenix score hits 2,
initiate aggressive resuscitation immediately.
Q2: A 45-year-old male without known cardiovascular disease presents for an annual exam. His
blood pressure is 134/86 mmHg. According to the 2025/2026 AHA/ACC High Blood Pressure
Guidelines, which tool is the INITIAL requirement to determine if antihypertensive
pharmacotherapy is indicated? A) The Pooled Cohort Equations (PCE) to assess 10-year
ASCVD risk. B) An immediate 24-hour ambulatory blood pressure monitor (ABPM). C) The
PREVENT-CVD equation to estimate the 10-year risk of total cardiovascular disease. D) An
electrocardiogram to assess for left ventricular hypertrophy.
● The Answer: C (The PREVENT-CVD equation to estimate the 10-year risk of total
cardiovascular disease.)
● Distractor Analysis:
○ A is incorrect: The PCE was retired in the 2025/2026 guidelines due to improved
calibration and the inclusion of heart failure in the newer PREVENT tool.
○ B is incorrect: While ABPM is useful for confirming resistant hypertension or
white-coat hypertension, it does not replace the risk-stratification calculation for
initiating therapy.
○ D is incorrect: End-organ damage assessment is secondary; the risk calculator
dictates the primary treatment threshold.
The Mentor's Analysis: The paradigm has shifted from isolated atherosclerosis prediction to
global cardiovascular-kidney-metabolic (CKM) risk. The PREVENT equation captures heart
failure and utilizes a lowered threshold (≥7.5%). Professional Intuition: Treat the patient's
global trajectory, not just the isolated sphygmomanometer reading.
Q3: Under the 2026 Global Initiative for Asthma (GINA) guidelines, which intervention is
, STRONGLY CONTRAINDICATED for the standalone management of a 22-year-old patient with
mild asthma? A) As-needed low-dose budesonide-formoterol. B) Daily low-dose inhaled
corticosteroids with as-needed short-acting beta-agonists. C) As-needed short-acting
beta-agonists (SABA) alone without concurrent anti-inflammatory therapy. D) Daily leukotriene
receptor antagonists.
● The Answer: C (As-needed short-acting beta-agonists (SABA) alone without concurrent
anti-inflammatory therapy.)
● Distractor Analysis:
○ A is incorrect: This is Track 1 (Preferred) therapy for mild asthma.
○ B is incorrect: This is Track 2 therapy, which is acceptable if Track 1 is unavailable
or unfeasible.
○ D is incorrect: While not first-line, LTRAs are not contraindicated, unlike standalone
SABAs.
The Mentor's Analysis: SABA monotherapy masks airway remodeling while providing a false
sense of security, directly leading to preventable asthma fatalities. Professional Intuition:
Never prescribe a bronchodilator without a structural fire extinguisher (ICS).
Q4: A 68-year-old patient arrives via EMS with an acute ischemic stroke (AIS) with symptom
onset 3 hours ago. The patient has disabling deficits. According to the 2026 AHA/ASA
guidelines, what is the PREFERRED intravenous thrombolytic strategy? A) Administer alteplase
exclusively, as newer agents are strictly investigational. B) Administer either alteplase or
tenecteplase without delaying for advanced perfusion imaging. C) Delay thrombolysis until an
MRI confirms the exact penumbra volume. D) Bypass intravenous thrombolysis entirely and
proceed directly to endovascular thrombectomy (EVT).
● The Answer: B (Administer either alteplase or tenecteplase without delaying for
advanced perfusion imaging.)
● Distractor Analysis:
○ A is incorrect: Tenecteplase (0.25 mg/kg) is fully endorsed and often preferred due
to its single-bolus administration.
○ C is incorrect: Advanced imaging (CTP/MRI) is for the extended window (4.5–24
hrs), not the standard 4.5-hour window.
○ D is incorrect: If eligible for both IVT and EVT, the guidelines mandate administering
IVT rapidly prior to or concurrent with EVT.
The Mentor's Analysis: Time is brain. Within the 4.5-hour window, standard non-contrast CT to
rule out hemorrhage is the only imaging barrier to the needle. Professional Intuition: Treat the
clot at the door; mechanical extraction is a concurrent pathway, never a reason to delay
chemical lysis.
Q5: A 55-year-old female presents with elevated liver enzymes, obesity, and type 2 diabetes.
Ultrasound reveals significant hepatic steatosis. She consumes zero alcohol. Under 2026
hepatology nomenclature, what is the MOST ACCURATE diagnostic term for her condition? A)
Non-Alcoholic Fatty Liver Disease (NAFLD). B) Metabolic Dysfunction-Associated Steatotic
Liver Disease (MASLD). C) Cryptogenic Cirrhosis. D) Alcohol-Associated Liver Disease (ALD).
● The Answer: B (Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).)
● Distractor Analysis:
○ A is incorrect: NAFLD is an obsolete, stigmatizing legacy term replaced in
2023/2026 by MASLD.
○ C is incorrect: She is not cirrhotic yet, and the etiology (metabolic) is clearly
identified.
○ D is incorrect: She consumes zero alcohol; Met-ALD requires 20-50g of alcohol per
